1 min read
Apnimed Posts $29.5 Million Q3 Loss as GAAP EPS Misses Estimates
The loss compared with $10.9 million in the quarter ended Sept. 30, 2025.

Apnimed, Inc. recorded a $29.5 million net loss in Q3 2026, while its GAAP earnings per share of -$1.05 missed estimates by $0.46 for the quarter ended Sept. 30.
The net loss was $10.9 million in the quarter ended Sept. 30, 2025.